Osteoarthritis (OA) is a progressive disease characterized by the deterioration of articular cartilage. Although most commonly reported in older patients, musculoskeletal injury is a major risk factor for the development and early onset of OA. Individuals typically present in the orthopaedic clinic when they experience symptoms of OA, however at this point the disease has irreversibly progressed through much of the cartilage. The inability to reliably detect cartilage damage noninvasively before it advances into OA hinders the development and/or use of chondroprotective and OA-modifying treatments. Therefore, we aim to functionally detect and model early cartilage damage in asymptomatic individuals, and translate this method into a clinica...
Background: The metabolic imbalance in the articular cartilage following meniscectomy includes an in...
ObjectiveLarge studies of knee osteoarthritis (KOA) require well-characterized efficient methods to ...
Introduction: At present, no disease-modifying osteoarthritis drugs (DMOADS) are approved by the FDA...
Osteoarthritis (OA) is a progressive disease characterized by the deterioration of articular cartila...
Articular cartilage is a connective tissue, that provides virtually frictionless articulation betwee...
Joint damage in osteoarthritis (OA) involves characteristic changes in multiple joint tissue types, ...
Osteoarthritis (OA) is the most common joint disorder worldwide, causing joint pain and stiffness. T...
INTRODUCTION Anterior cruciate ligament (ACL) rupture increases an individual’s risk of developing t...
With increasing life expectancies and the desire to maintain active lifestyles well into old age, th...
With increasing life expectancies and the desire to maintain active lifestyles well into old age, th...
[ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI AT AUTHOR'S REQUEST.] Arthritis is one of the leadi...
Osteoarthritis (OA) is a major debilitating health concern and economic burden worldwide, affecting ...
To address the need for early knee osteoarthritis (OA) markers by testing if longitudinal cartilage ...
Thesis (Ph.D.)--Boston UniversityOsteoarthritis (OA) is a chronic, progressive disease of diarthrodi...
Introduction: At present, no disease-modifying osteoarthritis drugs (DMOADS) are approved by the FDA...
Background: The metabolic imbalance in the articular cartilage following meniscectomy includes an in...
ObjectiveLarge studies of knee osteoarthritis (KOA) require well-characterized efficient methods to ...
Introduction: At present, no disease-modifying osteoarthritis drugs (DMOADS) are approved by the FDA...
Osteoarthritis (OA) is a progressive disease characterized by the deterioration of articular cartila...
Articular cartilage is a connective tissue, that provides virtually frictionless articulation betwee...
Joint damage in osteoarthritis (OA) involves characteristic changes in multiple joint tissue types, ...
Osteoarthritis (OA) is the most common joint disorder worldwide, causing joint pain and stiffness. T...
INTRODUCTION Anterior cruciate ligament (ACL) rupture increases an individual’s risk of developing t...
With increasing life expectancies and the desire to maintain active lifestyles well into old age, th...
With increasing life expectancies and the desire to maintain active lifestyles well into old age, th...
[ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI AT AUTHOR'S REQUEST.] Arthritis is one of the leadi...
Osteoarthritis (OA) is a major debilitating health concern and economic burden worldwide, affecting ...
To address the need for early knee osteoarthritis (OA) markers by testing if longitudinal cartilage ...
Thesis (Ph.D.)--Boston UniversityOsteoarthritis (OA) is a chronic, progressive disease of diarthrodi...
Introduction: At present, no disease-modifying osteoarthritis drugs (DMOADS) are approved by the FDA...
Background: The metabolic imbalance in the articular cartilage following meniscectomy includes an in...
ObjectiveLarge studies of knee osteoarthritis (KOA) require well-characterized efficient methods to ...
Introduction: At present, no disease-modifying osteoarthritis drugs (DMOADS) are approved by the FDA...